Last edition
News about " chronic hepatitis B"
AusperBio Doses First Patient in HBV Candidate AHB-171 Study
AusperBio has dosed the first patient in the AHB-171 clinical study, advancing its HBV pipeline and proprietary Au-HALO liver-targeting delivery technology siRNA platform.
Chronic Hepatitis B | 03/08/2026 | By News Bureau | 109
GSK Reports Positive Phase 3 Results for Bepirovirsen in Chronic Hepatitis B Treatment
GSK’s investigational antisense oligonucleotide bepirovirsen demonstrated statistically significant functional cure rates in chronic hepatitis B patients, offering a potential alternative to lifelong antiviral therapy.
Chronic Hepatitis B | 29/05/2026 | By News Bureau | 186
GSK Partners with Sino Biopharmaceutical to Accelerate Hepatitis B Therapy Launch in China
GSK and Sino Biopharmaceutical’s CTTQ have partnered to accelerate the launch of bepirovirsen in China, aiming to expand access to a potential first-in-class chronic hepatitis B therapy with functional cure potential.
Chronic Hepatitis B | 12/05/2026 | By News Bureau | 113
Hongene Biotech Supports SiranBio's Dual-Target siRNA Programme for Chronic Hepatitis B
Hongene Biotech provided end-to-end CDMO support for SiranBio’s SA1211 siRNA candidate, highlighting its capabilities in complex oligonucleotide therapeutic development and manufacturing.
Chronic Hepatitis B | 11/05/2026 | By News Bureau | 160
Japan's MHLW accepts GSK's Bepirovisen for Review to Treat Chronic Hepatitis B
Japan’s health ministry has accepted GSK’s new drug application for investigational antisense therapy bepirovirsen, after Phase III trials showed significantly higher functional cure rates in chronic hepatitis B patients.
Chronic Hepatitis B | 27/02/2026 | By News Bureau | 662
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy